In October, MedeAnalytics is recognizing Breast Cancer Awareness Month, a worldwide campaign to increase awareness, education and research about breast health and the importance of early detection. Breast cancer is the second most common kind of cancer in women, and one in eight women will get breast cancer in their life time. Through annual screenings like mammograms, women can survive breast cancer when it’s found and treated early.
Here’s how MedeAnalytics will recognize Breast Cancer Awareness Month:
- Our associates will be participating as a team, Mede Pirates of The Cure-Ribbean, in the Race for the Cure in Dallas on Saturday, October 26 and remote employees will be joining their local races.
- MedeAnalytics has partnered with Susan G. Komen to present a collaborative Lunch & Learn educational event hosted by Susan G. Komen ambassador Natasha Mmeje. MedeAnalytics’ employees will learn about the latest in breast cancer research and treatment resources.
- Wear Pink Wednesdays will be acknowledged throughout October to drive awareness
- Employees can share their personal stories of their loved ones and friends to show support on our internal message board
Join us as we participate in promoting this important message of hope and support.
Get our take on industry trends
Introduction to social risk: What healthcare leaders need to understand
‘Social determinants of health’ has been a common phrase for decades now, but the term social risk is much less…
Read on...AI is your new crystal ball: How predictive analytics can reduce denials
The idea of having a crystal ball to better understand what claims will be denied is an awesome concept. But one we can’t rely on. Thankfully, we have predictive analytics to take the place of a crystal ball.
Read on...3 ways to reduce friction in payer-provider relationships
The dynamic between healthcare providers and payers has historically been quite strained. Though both parties are interested in improving the…
Read on...Position your organization for success under CMS-HCC V28
The transition from CMS-HCC V24 to V28 heralds a significant shift in risk adjustment methodologies and emphasizes improved accuracy and…
Read on...